Ulrich Grabmaier Selected Research

Ulrich Grabmaier Research Topics

6	Myocarditis (Carditis) 10/2022 - 01/2019
5	Myocardial Infarction 01/2020 - 05/2015
4	Inflammation (Inflammations) 01/2023 - 01/2019
4	COVID-19 03/2022 - 01/2021
3	Hypertrophy 01/2018 - 05/2015
2	Out-of-Hospital Cardiac Arrest 10/2020 - 01/2018
2	Body Weight (Weight, Body) 10/2019 - 03/2014
2	Fibrosis (Cirrhosis) 01/2019 - 05/2015
2	Cardiomyopathies (Cardiomyopathy) 03/2014 - 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2023
1	Eosinophilia 01/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2023
1	Parasitic Diseases (Parasitic Disease) 01/2023
1	Edema (Dropsy) 09/2021
1	Malignant Mesothelioma 02/2021
1	Diplopia (Double Vision) 02/2021
1	Dyspnea (Shortness of Breath) 02/2021
1	Myasthenia Gravis 02/2021
1	Neoplasms (Cancer) 02/2021
1	Muscle Weakness 02/2021
1	Cicatrix (Scar) 01/2018
1	Hypoxia (Hypoxemia) 03/2017
1	Heart Failure 04/2016
1	Atrial Fibrillation 04/2016
1	Cardiomegaly (Heart Hypertrophy) 05/2015
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 11/2014
1	Wounds and Injuries (Trauma) 11/2014
1	Atherosclerosis 11/2014
1	Hyperplasia 11/2014
1	Primary Hyperparathyroidism 09/2014
1	Right Ventricular Dysfunction 03/2014
1	Heart Arrest (Cardiac Arrest) 04/2013

4	Sitagliptin Phosphate (Januvia)FDA Link 07/2016 - 11/2014
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2016 - 05/2015
2	TroponinIBA 09/2021 - 01/2021
2	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2022
1	AntibodiesIBA 10/2022
1	Serine (L-Serine)FDA Link 03/2022
1	Cysteine Proteinase InhibitorsIBA 03/2022
1	Complement System Proteins (Complement)IBA 03/2022
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	GadoliniumIBA 09/2021
1	Troponin T (Troponin T1)IBA 06/2021
1	ConnectinIBA 02/2021
1	pembrolizumabIBA 02/2021
1	Immune Checkpoint InhibitorsIBA 02/2021
1	AsbestosIBA 02/2021
1	AutoantibodiesIBA 02/2021
1	SteroidsIBA 02/2021
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 10/2019
1	MidkineIBA 01/2019
1	CytokinesIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Differentiation AntigensIBA 03/2017
1	picolinic acid (chromium picolinate)IBA 03/2017
1	MicroRNAs (MicroRNA)IBA 04/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2016
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2015
1	Parathyroid Hormone (Parathormone)IBA 09/2014
1	Simendan (Levosimendan)IBA 03/2014
1	Anesthetics (Anesthetic Agents)IBA 01/2014

8	Therapeutics 07/2023 - 04/2013
1	Plasma Exchange 02/2021
1	Resuscitation 10/2020
1	Transplantation 01/2020
1	Extracorporeal Membrane Oxygenation 03/2014